Search for Clinical Trial Results
Chromophobe Renal Cell Carcinoma - 1 Studies Found
| Status | Study |
| Not yet recruiting |
Study Name: A Study Evaluating the Safety, Pharmacokinetics and Anti-Tumor Activity of ABBV-176 in Subjects With Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR) Condition: Advanced Solid Tumors Likely to Express Prolactin Receptor (PRLR) Date: 2017-05-05 Interventions: Drug: ABBV-176 Intravenous infusion |